News
DRUP study in Nature
In 2016, the Drug Rediscovery Protocol was launched in the Netherlands. This is a unique and innovative pan-cancer clinical trial that seeks to expand the use of EMA and/or FDA-approved targeted therapies beyond their approved indications. In a Nature paper, published 30 September, the research team now takes stock of the progress of DRUP over the first three years.
2019. 10. 03.

In 2016, the Drug Rediscovery Protocol was launched in the Netherlands. This is a unique and innovative pan-cancer clinical trial that seeks to expand the use of EMA and/or FDA-approved targeted therapies beyond their approved indications. In a Nature paper, published 30 September, the research team now takes stock of the progress of DRUP over the first three years.

In the DRUP, patients with metastasized cancer without any further treatment options, are given a medicine that was registered for another cancer type.

The research leaders of DRUP are Oncode Investigator Emile Voest (the Netherlands Cancer Institute), Henk Verheul (Radboud University Medical Centre) and Hans Gelderblom (Leiden University Medical Centre).

Read the full article on the website of the Netherlands Cancer Institute:

https://www.nki.nl/topmenu/about-the-nki/news/the-drup-study-in-nature-taking-stock-of-the-first-three-years/